Krsnaa Diagnostics allots 16.21 lakh warrants at ₹566 each; promoters pay ₹22.94 crore upfront
As filed · Krsnaa Diagnostics Limited has informed the Exchange regarding allotment of 1621000 securities pursuant to Preferential Issue at its meeting held on October 13, 2026
What happened
FactKrsnaa Diagnostics allotted 16,21,000 fully convertible warrants on a preferential basis to promoter Rajendra Mutha and promoter-group entity Krsna Diagnostics (Mumbai) Private Limited. The company received 25% of the warrant issue price, amounting to ₹22,93,71,500; each warrant can convert into one equity share within 18 months, subject to payment of the remaining 75%.
Why it matters
CapitSignal interpretationShares are issued to named investors at a set price, diluting existing holders and changing who sits on the register.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Demand
RevisedRevenue from operations grew 22% YoY to ₹2,355 million, reflecting continued growth in the established business alongside contributions from newly commissioned projects.
Like-for-like projects grew approximately 12% YoY.
Change
FactImplication
CapitSignal interpretationDemand
RevisedLike-for-like projects grew approximately 12% YoY.
Retail revenue grew approximately 64% YoY and 22% sequentially to ₹193 million, with the retail network expanding to more than 4,250 touchpoints across five states.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Who the allottees are
- Issue price versus market price
- Lock-in period on the new shares
- And on the RPL side, we are targeting about 20% of revenue in one or two years. (management committed by FY27)
- We see today and expect retail to account for 8% to 10% revenue in the FY '26 to accelerate to the tune and co (management committed by FY27)
Evidence
- Krsnaa Diagnostics Limited has informed the Exchange regarding allotment of 1621000 securities pursuant to Preferential Issue at its meeting held on October 13, 2026(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- The allotment provides ₹22.94 crore of upfront funding from promoter and promoter-group subscribers and could result in 16.21 lakh new equity shares if the warrants are converted. Paid-up share capital does not change at the allotment stage.
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%